Journal article · 2002 · Open access

4-1BB-Specific Monoclonal Antibody Promotes the Generation of Tumor-Specific Immune Responses by Direct Activation of CD8 T Cells in a CD40-Dependent Manner

Robert E. Miller, Jon Jones, Tiep Le, James Boyd Whitmore, Norman Boiani, Brian Gliniak, David H. Lynch

The Journal of Immunology, 169(4), 1792–1800 · Published 1 August 2002 · DOI 10.4049/jimmunol.169.4.1792

Open PDFView at the publisherCite this paper

In brief

“4-1BB-Specific Monoclonal Antibody Promotes the Generation of Tumor-Specific Immune Responses by Direct Activation of CD8 T Cells in a CD40-Dependent Manner” is a 2002 journal article by Robert E. Miller and 6 co-authors, published in The Journal of Immunology. OpenAlex counts 146 citations as of 18 November 2026. It is open access: the full text is free to read at The Journal of Immunology.

Citations
146
Most cited in
2017 (6)
Field-weighted impact
2.85
References
51
Authors
7

Abstract

4-1BB (CD137) is a member of the TNFR superfamily (TNFRSF9). T cell expression of 4-1BB is restricted to activated cells, and cross-linking has been shown to deliver a costimulatory signal. Here we have shown that treatment of tumor-bearing mice with agonistic 4-1BB-specific Abs can lead to T cell-mediated tumor rejection. In vivo mAb depletion experiments demonstrated that this rejection requires CD8(+) cells but not CD4(+) or NK cells. Both IFN-gamma- and CD40-mediated signals were also required, because no benefit was observed on treatment with 4-1BB mAb in mice in which the genes for these molecules had been knocked out. Interestingly, 4-1BB-mediated stimulation of immune responses in CD40L(-/-) mice is effective (although at a reduced level), and may suggest the existence of an alternative ligand for CD40. Additional experiments in IL-15(-/-) mice indicate that IL-15 is not required for either the generation of the primary tumor-specific immune response or the maintenance of the memory immune response. In contrast, the presence of CD4 cells during the primary immune response appears to play a significant role in the maintenance of effective antitumor memory. Finally, in mice in which the number of dendritic cells had been expanded by Fms-like tyrosine kinase3 ligand treatment, the antitumor effects of 4-1BB ligation were enhanced.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Miller, R. E., Jones, J., Le, T., Whitmore, J. B., Boiani, N., Gliniak, B., & Lynch, D. H. (2002). 4-1BB-Specific Monoclonal Antibody Promotes the Generation of Tumor-Specific Immune Responses by Direct Activation of CD8 T Cells in a CD40-Dependent Manner. The Journal of Immunology, 169(4), 1792–1800. https://doi.org/10.4049/jimmunol.169.4.1792

MLA 9

Miller, Robert E., et al. “4-1BB-Specific Monoclonal Antibody Promotes the Generation of Tumor-Specific Immune Responses by Direct Activation of CD8 T Cells in a CD40-Dependent Manner.” The Journal of Immunology, vol. 169, no. 4, 2002, pp. 1792–1800. https://doi.org/10.4049/jimmunol.169.4.1792.

Chicago

Miller, Robert E., Jon Jones, Tiep Le, James Boyd Whitmore, Norman Boiani, Brian Gliniak, and David H. Lynch. 2002. “4-1BB-Specific Monoclonal Antibody Promotes the Generation of Tumor-Specific Immune Responses by Direct Activation of CD8 T Cells in a CD40-Dependent Manner.” The Journal of Immunology 169 (4): 1792–1800. https://doi.org/10.4049/jimmunol.169.4.1792.

Harvard

Miller, R. E. et al. (2002) ‘4-1BB-Specific Monoclonal Antibody Promotes the Generation of Tumor-Specific Immune Responses by Direct Activation of CD8 T Cells in a CD40-Dependent Manner’, The Journal of Immunology, 169(4), pp. 1792–1800. doi:10.4049/jimmunol.169.4.1792.

IEEE

R. E. Miller et al., “4-1BB-Specific Monoclonal Antibody Promotes the Generation of Tumor-Specific Immune Responses by Direct Activation of CD8 T Cells in a CD40-Dependent Manner,” The Journal of Immunology, vol. 169, no. 4, pp. 1792–1800, 2002, doi: 10.4049/jimmunol.169.4.1792.

BibTeX

@article{miller2002specific,
  title     = {{4-1BB-Specific Monoclonal Antibody Promotes the Generation of Tumor-Specific Immune Responses by Direct Activation of CD8 T Cells in a CD40-Dependent Manner}},
  author    = {Miller, Robert E. and Jones, Jon and Le, Tiep and Whitmore, James Boyd and Boiani, Norman and Gliniak, Brian and Lynch, David H.},
  journal   = {The Journal of Immunology},
  year      = {2002},
  volume    = {169},
  number    = {4},
  pages     = {1792--1800},
  doi       = {10.4049/jimmunol.169.4.1792},
  url       = {https://doi.org/10.4049/jimmunol.169.4.1792}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201766
201811
201944
202033
202111
202233
202322
202411
202511
202611

Its field-weighted citation impact is 2.85: it has been cited 2.85 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses

  • 4-1BB
  • agonistic monoclonal antibody
  • CD8+ T cells
  • CD40
  • CD40 ligand
  • tumor-specific immunity
  • antitumor immunity
  • interferon-gamma

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Miller, R. E., Jones, J., Le, T., Whitmore, J. B., Boiani, N., Gliniak, B., & Lynch, D. H. (2002). 4-1BB-Specific Monoclonal Antibody Promotes the Generation of Tumor-Specific Immune Responses by Direct Activation of CD8 T Cells in a CD40-Dependent Manner. The Journal of Immunology, 169(4), 1792–1800. https://doi.org/10.4049/jimmunol.169.4.1792

How many times has this paper been cited?

146 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at The Journal of Immunology: sign in and open the PDF from this page.

Who wrote this paper?

Robert E. Miller, Jon Jones, Tiep Le, James Boyd Whitmore, Norman Boiani, Brian Gliniak, David H. Lynch.

What is the DOI of this paper?

10.4049/jimmunol.169.4.1792, permanently at https://doi.org/10.4049/jimmunol.169.4.1792. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.